Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs
暂无分享,去创建一个
G. Calin | C. Ivan | G. Packham | M. Bullock | J. Primrose | G. Thomas | A. Mirnezami | R. Mitter | A. E. Sayan | K. Pickard
[1] George A Calin,et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.
[2] O. Lingjaerde,et al. Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment , 2014, Molecular oncology.
[3] F. Sánchez‐Madrid,et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.
[4] G. Packham,et al. miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance. , 2013, Cancer research.
[5] Yoshiyuki Yamamoto,et al. Fecal miR-106a Is a Useful Marker for Colorectal Cancer Patients with False-Negative Results in Immunochemical Fecal Occult Blood Test , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[6] B. Nielsen,et al. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression , 2013, Cell Death and Disease.
[7] G. Packham,et al. FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role , 2013, British Journal of Cancer.
[8] Y. Toiyama,et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. , 2013, Journal of the National Cancer Institute.
[9] D. Scadden,et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. , 2013, The Journal of clinical investigation.
[10] P. Gibbs,et al. Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors. , 2013, Critical reviews in oncology/hematology.
[11] Min Liu,et al. MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. , 2012, Cancer letters.
[12] S. Rai,et al. Plasma MiR-21: A Potential Diagnostic Marker of Colorectal Cancer , 2012, Annals of surgery.
[13] M. Zheng,et al. Colorectal Cancer Migration and Invasion Initiated by microRNA-106a , 2012, PloS one.
[14] Kazuo Ikeda,et al. Induction of microRNA-214-5p in human and rodent liver fibrosis , 2012, Fibrogenesis & tissue repair.
[15] Gerald Hoefler,et al. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. , 2012, Carcinogenesis.
[16] Kenichi Sugihara,et al. Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters , 2012, Clinical Cancer Research.
[17] M. Fukushima,et al. Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells , 2012, Journal of Gastroenterology.
[18] Ara Darzi,et al. Preparing for precision medicine. , 2012, The New England journal of medicine.
[19] A. Eggermont,et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population‐based series , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[20] Michael C. Ostrowski,et al. Reprogramming of the Tumor Microenvironment by Stromal Pten-regulated miR-320 , 2011, Nature Cell Biology.
[21] Yi Zheng,et al. miR‐21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells , 2011, FEBS letters.
[22] F. Su,et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.
[23] Jun Yu,et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps , 2011, Gut.
[24] A. Gaur,et al. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. , 2011, Neuro-oncology.
[25] Timothy R Pal,et al. Prognostic significance of miR-215 in colon cancer. , 2011, Clinical colorectal cancer.
[26] M. Wei,et al. Micro‐RNA‐21 regulates TGF‐β‐induced myofibroblast differentiation by targeting PDCD4 in tumor‐stroma interaction , 2011, International journal of cancer.
[27] H. Nielsen,et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients , 2010, Clinical & Experimental Metastasis.
[28] Jing Li,et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. , 2010, Molecular cell.
[29] Mark E. Davis,et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.
[30] J. Ferlay,et al. Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.
[31] C. Kang,et al. Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells , 2010, Technology in cancer research & treatment.
[32] Lei Han,et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol , 2010, BMC Cancer.
[33] S. Kauppinen,et al. Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.
[34] Marek Svoboda,et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application , 2009, Molecular Cancer.
[35] A. Schetter,et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers , 2009, Proceedings of the National Academy of Sciences.
[36] K. Ohuchida,et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance , 2009, Molecular Cancer Therapeutics.
[37] R. Gregory,et al. Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.
[38] Xin Zhang,et al. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. , 2008, Cancer research.
[39] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[40] C. Klein,et al. The Metastasis Cascade , 2008, Science.
[41] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[42] T. Wurdinger,et al. MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.
[43] E. Labourier,et al. Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. , 2008, The Journal of molecular diagnostics : JMD.
[44] H. Allgayer,et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.
[45] George A Calin,et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.
[46] Kazuhiko Hayashi,et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.
[47] K. Ghoshal,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.
[48] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[49] J. Ferlay,et al. Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[50] C. Lepage,et al. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population , 2006, The British journal of surgery.
[51] A. Shorthouse,et al. Association of Coloproctology of Great Britain and Ireland: News , 1999 .
[52] W. Sauerbrei,et al. Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.
[53] A. Benson,et al. Adjuvant therapy in stage II colon cancer: current approaches. , 2005, The oncologist.
[54] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[55] D. Sargent,et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] Jason E. Stewart,et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.
[57] 陆星华,et al. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis , 2001 .
[58] P. Simmonds,et al. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis , 2000, BMJ : British Medical Journal.
[59] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[60] K. Okuno,et al. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. , 1997, Journal of the American College of Surgeons.
[61] P. Quirke,et al. Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer , 1995, The British journal of surgery.
[62] E. van Rooij,et al. MicroRNA-214 antagonism protects against renal fibrosis. , 2014, Journal of the American Society of Nephrology : JASN.
[63] Alberto Izzotti,et al. MicroRNAs in cancer treatment and prognosis. , 2012, American journal of cancer research.
[64] Jing Liu,et al. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN , 2012, Molecular and Cellular Biochemistry.
[65] I. Fidler,et al. Cancer metastasis. , 1991, British medical bulletin.